Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjiang Chen

Showing results (11-20 of 279) with videos related to

Pageof 28
Sort By:
Asia-Pacific Journal of Clinical Oncology|June 24, 2020
Renal immune-related adverse events of immune checkpoint inhibitorRongrong Hu, Minjiang Chen, Yan Xu, et al.
Asia-Pacific Journal of Clinical Oncology|February 21, 2020
Recognition and management of the gastrointestinal and hepatic immune-related adverse eventsBei Tan, Yue Li, Yan Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 10, 2025
[Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation 
Sensitive to Furmonertinib: A Case Report]Rongzhen Li, Yan Xu, Xiaoxing Gao, et al.
Journal of Nanoscience and Nanotechnology|May 8, 2013
Fluorination of edges and central areas of monolayer graphene by SF6 and CHF3 plasma treatmentsMinjiang Chen, Caiyu Qiu, Haiqing Zhou, et al.
Chemical Communications (Cambridge, England)|December 14, 2011
Preferential elimination of thin single-walled carbon nanotubes by iron etchingFang Yu, Haiqing Zhou, Huaichao Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 4, 2019
LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1Janfei Tu, Zhongwei Zhao, Min Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 27, 2016
[Clinical Features of Intradural Extramedullary Spinal Cord Metastases 
in Primary Lung Cancer]Yan Xu, Wei Zhong, Jing Zhao, et al.
Frontiers in Immunology|May 27, 2021
Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer PatientMinjiang Chen, Lei Zhang, Wei Zhong, et al.
Oncotarget|November 22, 2017
Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?Xiaoyan Liu, Qing Zhou, Yan Xu, et al.
Nanotechnology|March 3, 2012
Layer-dependent fluorination and doping of graphene via plasma treatmentMinjiang Chen, Haiqing Zhou, Caiyu Qiu, et al.
Pageof 28

Showing results (11-20 of 279) with videos related to

Sort By:
Pageof 28
Asia-Pacific Journal of Clinical Oncology|June 24, 2020
Renal immune-related adverse events of immune checkpoint inhibitorRongrong Hu, Minjiang Chen, Yan Xu, et al.
Asia-Pacific Journal of Clinical Oncology|February 21, 2020
Recognition and management of the gastrointestinal and hepatic immune-related adverse eventsBei Tan, Yue Li, Yan Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 10, 2025
[Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation 
Sensitive to Furmonertinib: A Case Report]Rongzhen Li, Yan Xu, Xiaoxing Gao, et al.
Journal of Nanoscience and Nanotechnology|May 8, 2013
Fluorination of edges and central areas of monolayer graphene by SF6 and CHF3 plasma treatmentsMinjiang Chen, Caiyu Qiu, Haiqing Zhou, et al.
Chemical Communications (Cambridge, England)|December 14, 2011
Preferential elimination of thin single-walled carbon nanotubes by iron etchingFang Yu, Haiqing Zhou, Huaichao Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 4, 2019
LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1Janfei Tu, Zhongwei Zhao, Min Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 27, 2016
[Clinical Features of Intradural Extramedullary Spinal Cord Metastases 
in Primary Lung Cancer]Yan Xu, Wei Zhong, Jing Zhao, et al.
Frontiers in Immunology|May 27, 2021
Case Report: THSD7A-Positive Membranous Nephropathy Caused by Tislelizumab in a Lung Cancer PatientMinjiang Chen, Lei Zhang, Wei Zhong, et al.
Oncotarget|November 22, 2017
Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?Xiaoyan Liu, Qing Zhou, Yan Xu, et al.
Nanotechnology|March 3, 2012
Layer-dependent fluorination and doping of graphene via plasma treatmentMinjiang Chen, Haiqing Zhou, Caiyu Qiu, et al.
Pageof 28